Drug profile · INN
olive oil
CLINOLIPID 20%
olive oil (CLINOLIPID 20%) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — olive oil
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 4
- Programs
- 1
- Data quality
- 0.84
Quick answer
olive oil (CLINOLIPID 20%) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 11052123
Method of obtaining olive oil and extracts from olives
granted -
US 6361803
Antioxidant compositions extracted from a wastewater from olive oil production
expired -
US 6319691
Fusion proteins comprising IFN-alpha2b and TM-alpha1
expired -
US 6204360
Retro-inverso thymosin alpha 1 hybrids
expired
Frequently asked questions
What is olive oil?
olive oil (CLINOLIPID 20%) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for olive oil?
CLINOLIPID 20% is a marketed brand name for olive oil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of olive oil?
olive oil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.